Published in
Taylor and Francis Group, OncoImmunology, 3(7), p. e1398874
DOI: 10.1080/2162402x.2017.1398874
Links
Tools
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment
Journal article published in 2017 by
Chiara Riganti,
Marcello Francesco Lingua,
Iris Chiara Salaroglio,
Chiara Falcomatà 
,
Luisella Righi ,
Deborah Morena,
Francesca Picca,
Daniele Oddo ,
Joanna Kopecka,
Monica Pradotto,
Roberta Libener,
Sara Orecchia,
Paolo Bironzo ,
Valentina Comunanza ,
Federico Bussolino
and other authors.
,
Luisella Righi ,
Deborah Morena,
Francesca Picca,
Daniele Oddo ,
Joanna Kopecka,
Monica Pradotto,
Roberta Libener,
Sara Orecchia,
Paolo Bironzo ,
Valentina Comunanza ,
Federico Bussolino
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 